ReviewClinical ophthalmology (Auckland, N.Z.)2026
Acute Invasive Fungal Rhino-Orbital Sinusitis: Current Concepts and Controversies.
Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute invasive fungal rhinosinusitis (AIFRS) is a fulminant angioinvasive infection that primarily affects immunocompromised patients and carries substantial morbidity and mortality. Orbital involvement presents particular diagnostic and therapeutic challenges and remains an area of controversy. This review summarizes current concepts in the classification, microbiology, diagnosis, and management of AIFRS, with emphasis on orbital involvement, termed acute invasive fungal rhino-orbital sinusitis (AIFROS). Early recognition, urgent imaging, histopathologic diagnosis, systemic antifungal therapy, debridement of necrotic tissue, and reversal of underlying immunosuppression remain the cornerstones of treating AIFRS. In contrast, management of AIFROS remains less standardized; globe-sparing approaches are increasingly employed in selected patients, as the literature has not demonstrated a clear survival benefit from orbital exenteration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.